Isolated lymphoma of the choroid plexus: a case report

Abstract

The choroid plexus, pivotal for cerebrospinal fluid (CSF) regulation and blood-CSF barrier function, becomes a focal point for primary central nervous system lymphoma (PCNSL). This article delves into a case of this uncommon presentation, highlighting diagnostic challenges, treatment complexities, and post-treatment outcomes. A 30-year-old Lebanese patient with mild headaches and vomiting was initially diagnosed with vasculitis but later confirmed through endoscopic biopsy to have diffuse large B-cell lymphoma of the choroid plexus. Treatment with intravenous methotrexate, intrathecal cytarabine, rituximab, and radiotherapy led to gradual neurological improvement. Treatment strategies, aligned with PCNSL standards, include intravenous methotrexate, intrathecal cytarabine, rituximab, and radiotherapy, leading to gradual neurological improvement post-treatment. Prognostic factors, such as age and specific brain area involvement, guide tailored treatment plans. This report emphasizes the need for a multidisciplinary approach, increased awareness, and ongoing research for optimal outcomes in PCNSL cases involving the choroid plexus.

Keywords

PCNSL / choroid plexus / intravenous methotrexate / intrathecal cytarabine

References

[1] Lun MP,Monuki ES,Lehtinen MK.Development and functions of the choroid plexus-cerebrospinal fluid system.Nat Rev Neurosci.2015;16:445-57.

[2] Löw S,Han CH,Batchelor TT.Primary central nervous system lymphoma.Ther Adv Neurol Disord.2018;11:1756286418793562.

[3] Grommes C,DeAngelis LM.Primary CNS Lymphoma.J Clin Oncol.2017;35:2410-8.

[4] Jaiswal S,Vij M,Mehrotra A,Kumar B,Nair A,Jaiswal AK,et al.Choroid plexus tumors: A clinico-pathological and neuro-radiological study of 23 cases.Asian J Neurosurg.2013;8:29-35.

[5] Wang CC,Carnevale J,Rubenstein JL.Progress in central nervous system lymphomas.Br J Haematol.2014;166:311-25.

[6] Scott BJ,Douglas VC,Tihan T,Rubenstein JL,Josephson SA.A systematic approach to the diagnosis of suspected central nervous system lymphoma.JAMA Neurol.2013;70:311-9.

[7] Primary CNS Lymphoma Treatment (PDQ^®)–Patient Version [Internet]National Cancer Institute. Available from: https://www.cancer.gov/types/lymphoma/patient/primary-cns-lymphoma-treatment-pdq

[8] Ferreri AJ,Cwynarski K,Pulczynski E,Ponzoni M,Deckert M,Politi LS,et al.International Extranodal Lymphoma Study Group (IELSG).Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.Lancet Haematol.2016;3:e217-27.

[9] Yang XL,Liu YB.Advances in Pathobiology of Primary Central Nervous System Lymphoma.Chin Med J (Engl).2017;130:1973-9.

[10] Zheng W,Song Y,Xie Y,Lin N,Tu M,Liu W,et al.Cerebrospinal Fluid Proteins Identification Facilitates the Differential Diagnosis of Central Nervous System Diffuse Large B Cell Lymphoma.J Cancer.2017;8:3631-40.

[11] Suri V,Mittapalli V,Kulshrestha M,Premlani K,Sogani SK,Suri K.Primary intraventricular central nervous system lymphoma in an immunocompetent patient.J Pediatr Neurosci.2015;10:393-5.